{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:30:57Z","timestamp":1791595857316,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023692","name":"The Peter Doherty Institute for Infection and Immunity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1006592"],"award-info":[{"award-number":["1006592"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1045549"],"award-info":[{"award-number":["1045549"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1052979"],"award-info":[{"award-number":["1052979"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1065626"],"award-info":[{"award-number":["1065626"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154970"],"award-info":[{"award-number":["1154970"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["118864"],"award-info":[{"award-number":["118864"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020730","name":"Walter and Eliza Hall Institute of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.xcrm.2023.101178","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:32:44Z","timestamp":1693391564000},"page":"101178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice"],"prefix":"10.1016","volume":"4","author":[{"given":"Philip","family":"Arandjelovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youry","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Doerflinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Zerbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Tumpach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesslyn","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Sheerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon K.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody C.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3627-3126","authenticated-orcid":false,"given":"Marc","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101178_bib1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T\u00a0cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101178_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","article-title":"Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection","volume":"24","author":"Colby","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib4","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.xcrm.2023.101178_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005237","article-title":"Modeling the Effects of Vorinostat In\u00a0Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells","volume":"11","author":"Ke","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101178_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101178_bib7","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study","volume":"2","author":"Elliott","year":"2015","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.xcrm.2023.101178_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1083\/jcb.201405051","article-title":"Casp8p41 generated by HIV protease kills CD4 T\u00a0cells through direct Bak activation","volume":"206","author":"Sainski","year":"2014","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101178_bib9","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/JVI.03179-15","article-title":"Prime, Shock, and Kill: Priming CD4\u00a0T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size","volume":"90","author":"Cummins","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101178_bib10","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1172\/JCI132374","article-title":"BCL-2 antagonism sensitizes cytotoxic t\u00a0cell-resistant hiv reservoirs to elimination ex\u00a0vivo","volume":"130","author":"Ren","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101178_bib11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1133289","article-title":"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak","volume":"315","author":"Willis","year":"2007","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.xcrm.2023.101178_bib12","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1073\/pnas.1005256107","article-title":"BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs","volume":"107","author":"Carrington","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101178_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib14","doi-asserted-by":"crossref","first-page":"279ra40","DOI":"10.1126\/scitranslmed.aaa4642","article-title":"Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy","volume":"7","author":"Leverson","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1470-2045(16)30019-5","article-title":"Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study","volume":"17","author":"Stilgenbauer","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2023.101178_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00012-17","article-title":"Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition","volume":"91","author":"Cummins","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101178_bib18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/cdd.2017.30","article-title":"Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in\u00a0vitro and in\u00a0vivo","volume":"24","author":"Carrington","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2023.101178_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/leu.2017.243","article-title":"Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1","volume":"32","author":"Teh","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2023.101178_bib20","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-18-1151","article-title":"A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer","volume":"9","author":"Lok","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101178_bib21","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005535","article-title":"Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV","volume":"12","author":"Hill","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101178_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ T\u00a0cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40262-019-00818-5","article-title":"Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus","volume":"59","author":"Nader","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.xcrm.2023.101178_bib27","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/bloodadvances.2022008221","article-title":"Venetoclax treatment in cancer patients has limited impact on circulating T and NK cells","volume":"7","author":"Teh","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2023.101178_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ebiom.2015.06.019","article-title":"A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals","volume":"2","author":"Procopio","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2023.101178_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006505","article-title":"HIV-1 infection depletes human CD34+CD38- hematopoietic progenitor cells via pDC-dependent mechanisms","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101178_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature19830","article-title":"The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models","volume":"538","author":"Kotschy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/cdd.2013.25","article-title":"Mcl-1 antagonizes Bax\/Bak to promote effector CD4(+) and CD8(+) T-cell responses","volume":"20","author":"Tripathi","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2023.101178_bib33","doi-asserted-by":"crossref","first-page":"12385","DOI":"10.1128\/JVI.00609-14","article-title":"Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies","volume":"88","author":"Vandergeeten","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101178_bib34","doi-asserted-by":"crossref","first-page":"16934","DOI":"10.1073\/pnas.1002894107","article-title":"Establishment of HIV-1 latency in resting CD4+ T\u00a0cells depends on chemokine-induced changes in the actin cytoskeleton","volume":"107","author":"Cameron","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101178_bib35","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.4049\/jimmunol.1100102","article-title":"Bcl-2 Allows Effector and Memory CD8+ T Cells To Tolerate Higher Expression of Bim","volume":"186","author":"Kurtulus","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101178_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2011.34.7898","article-title":"Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease","volume":"30","author":"Roberts","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101178_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41586-022-05556-6","article-title":"HIV silencing and cell survival signatures in infected T\u00a0cell reservoirs","volume":"614","author":"Clark","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-022-05538-8","article-title":"Phenotypic signatures of immune selection in HIV-1 reservoir cells","volume":"614","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02425-20","article-title":"Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex\u00a0Vivo Reservoirs","volume":"95","author":"Ren","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101178_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/MCB.01155-09","article-title":"Functional Cooperation of the Proapoptotic Bcl2 Family Proteins Bmf and Bim In\u00a0Vivo","volume":"30","author":"H\u00fcbner","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101178_bib41","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1158\/1078-0432.CCR-15-3057","article-title":"Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells","volume":"22","author":"Niu","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101178_bib42","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1111\/febs.14505","article-title":"Phosphorylation alters Bim-mediated Mcl-1 stabilization and priming","volume":"285","author":"Conage-Pough","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.xcrm.2023.101178_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.12","article-title":"Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells","volume":"2","author":"Luedtke","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2023.101178_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2019.03.004","article-title":"Between a shock and a hard place: challenges and developments in HIV latency reversal","volume":"38","author":"Zerbato","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2023.101178_bib45","doi-asserted-by":"crossref","first-page":"e60933","DOI":"10.7554\/eLife.60933","article-title":"Phenotypic analysis of the unstimulated in\u00a0vivo HIV CD4 T\u00a0cell reservoir","volume":"9","author":"Neidleman","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.xcrm.2023.101178_bib46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1+ and follicular helper T\u00a0cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib47","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3389\/fmicb.2016.01944","article-title":"Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation","volume":"7","author":"Tsunetsugu-Yokota","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101178_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008450","article-title":"Tissue memory CD4+ T\u00a0cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection","volume":"16","author":"Hsiao","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101178_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007991","article-title":"Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations","volume":"15","author":"Grau-Exp\u00f3sito","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101178_bib50","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/cid\/ciz378","article-title":"Genetic Evidence That Naive T Cells Can Contribute Significantly to the Human Immunodeficiency Virus Intact Reservoir: Time to Re-evaluate Their Role","volume":"69","author":"Venanzi Rullo","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101178_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150794","article-title":"Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication","volume":"6","author":"Pinzone","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2023.101178_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133157","article-title":"Persistence of an intact HIV reservoir in phenotypically naive T\u00a0cells","volume":"5","author":"Venanzi Rullo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2023.101178_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T\u00a0cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib54","first-page":"E2575","article-title":"Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101178_bib55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101178_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132997","article-title":"Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy","volume":"5","author":"Peluso","year":"2020","journal-title":"Jci Insight"},{"key":"10.1016\/j.xcrm.2023.101178_bib58","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiab121","article-title":"Gag p24 is a Marker of HIV Expression in Tissues and Correlates with Immune Response","volume":"224","author":"Wu","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101178_bib59","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","article-title":"Defining total-body AIDS-virus burden with implications for curative strategies","volume":"23","author":"Estes","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib60","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1073\/pnas.1406663111","article-title":"Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1","volume":"111","author":"Hill","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101178_bib61","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/cid\/ciz108","article-title":"Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1","volume":"69","author":"Zerbato","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101178_bib62","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of Genetically Intact HIV-1 Proviruses in Specific CD4(+) T Cells from Effectively Treated Participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101178_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood-2006-04-017681","article-title":"Hematopoietic stem cell-engrafted NOD\/SCID\/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses","volume":"109","author":"Watanabe","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101178_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02118-17","article-title":"HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART","volume":"92","author":"Satheesan","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101178_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-020-00516-2","article-title":"Benefits and limitations of humanized mice in HIV persistence studies","volume":"17","author":"Marsden","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2023.101178_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11904-009-0003-2","article-title":"Novel humanized murine models for HIV research","volume":"6","author":"Denton","year":"2009","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.xcrm.2023.101178_bib67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib68","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101178_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/jis630","article-title":"Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T\u00a0cells","volume":"208","author":"Hatano","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101178_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/3aa92c3d-b6dd-4c6e-8cee-9587ce80a9c9","article-title":"Gag-Positive Reservoir Cells Are Susceptible to HIV-Specific Cytotoxic T Lymphocyte Mediated Clearance","volume":"8","author":"Graf","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101178_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01730-22","article-title":"The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin\/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model","volume":"96","author":"Chandrasekar","year":"2022","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101178_bib72","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/dmd.116.071613","article-title":"Absorption,\u00a0Metabolism, and Excretion of a Novel Bcl-2 Inhibitor Venetoclax in Humans","volume":"45","author":"Liu","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.xcrm.2023.101178_bib73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1479-7364-1-4-300","article-title":"Cytochrome P450 humanised mice","volume":"1","author":"Gonzalez","year":"2004","journal-title":"Hum. Genom."},{"key":"10.1016\/j.xcrm.2023.101178_bib74","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","article-title":"Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B\/2A trial","volume":"3","author":"Leth","year":"2016","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.xcrm.2023.101178_bib75","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.chom.2018.09.007","article-title":"SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells","volume":"24","author":"Campbell","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101178_bib76","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","article-title":"Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys","volume":"563","author":"Borducchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101178_bib77","first-page":"1","article-title":"Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial","author":"Gunst","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib78","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cell.2021.12.011","article-title":"Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses","volume":"185","author":"Einkauf","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101178_bib79","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1038\/s41467-023-39837-z","article-title":"Impact of misclassified defective proviruses on HIV reservoir measurements","volume":"14","author":"Reeves","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101178_bib80","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1084\/jem.20190896","article-title":"Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir","volume":"216","author":"Gaebler","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101178_bib81","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkz114","article-title":"The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101178_bib82","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101178_bib83","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101178_bib84","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101178_bib85","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1214\/16-AOAS920","article-title":"Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression","volume":"10","author":"Phipson","year":"2016","journal-title":"Ann. Appl. Stat."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123003312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123003312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:57:02Z","timestamp":1762988222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123003312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2666379123003312"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101178","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101178"}}